The 102nd edition of the HPRA Drug Safety Newsletter includes information about the conclusion of the European Medicines Agency's (EMA) review of thromboembolic events following vaccination with Covid-19 Vaccine AstraZeneca.
The online versions of the DSN contains hyperlinks to product information and other documents on the HPRA and EMA websites, as appropriate.